Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009

Eurosurveillance

Volumn 16, Issue 41, 2011, Pages 4-

  Wielders, C C ^a,b   van Binnendijk, R S ^a   Snijders, B E ^a,b   Tipples, G A ^c   Cremer, J ^a   Fanoy, E ^a,d   Dolman, S ^e   Ruijs, W L ^a,f   Boot, H J ^a   de Melker, H E ^a   Hahne S J ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Pallas Health Research and Consultancy BV   (Netherlands)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Municipal Health Service (GGD) 'Midden Nederland'   (Netherlands)

^e Ministry of Health/Long Term Care   (Canada)

^f Municipal Health Service (GGD) 'Rivierenland'   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHILD; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; GENERAL PRACTITIONER; GENOTYPE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; RELIGION; SCHOOL CHILD; VACCINATION; VIROLOGY; VIRUS DETECTION; VIRUS STRAIN;

EID: 80054829679     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371(9616):932-944.
2. Kemmeren JM, de Melker HE. The National Immunisation Programme in the Netherlands. Developments in 2009. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2010. Report 210021012/2010. Available from: http://www.rivm.nl/bibliotheek/rapporten/210021012.pdf
3. van Lier EA, Oomen PJ, Oostenbrug MW, Zwakhals SL, Drijfhout IH, de Hoogh PA, et al. [High vaccination coverage of the National Immunization Programme in the Netherlands]. Ned Tijdschr Geneeskd. 2009;153(20):950-957. Dutch.
4. Ruijs WL, Hautvast JL, van der Velden K, de Vos S, Knippenberg H, Hulscher ME. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health. 2011;11:102.
5. Zwakhals SLN, van Lier EA. BMR per gemeente 2010 (zuigelingen) [MMR-1 coverage by municipality 2010 (infants)]. Dutch Public Health Status and Forecast studies, National Compass of Public Health. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2010. [Accessed 19 Jan 2011]. Dutch. Available from: http://www.zorgatlas.nl/preventie/vaccinaties-en-screening/bmr-per-gemeente-2010-zuigelingen/#breadcrumb
6. Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, van't Spijker K, Hulscher ME, et al. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health. 2011 Jun 29. [Epub ahead of print].
7. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, Fanoy E, et al. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill. 2008;13(24):pii=18901. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18901
8. van den Hof S, Conyn-van Spaendonck MAE, de Melker HE, Geubbels ELPE, Suijkerbuijk AWM, Talsma E, et al. The effects of vaccination, the incidence of the target diseases. Bilthoven: National Institute for Public Health and the Environment (RIVM); 1998. RIVM report 213676008. Available from: http://www.rivm.nl/bibliotheek/rapporten/213676008.pdf
9. Public Health Agency of Canada. National notifiable diseases. Public Health Agency of Canada; 2005. [Accessed 20 Jul 2011]. Available from: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/list-eng.php
10. Public Health Agency of Canada. Canadian national report on immunization, 2006. 2006. Can Commun Dis Rep.2006;32 S3:1-44. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06pdf/32s3_e.pdf
11. Furesz J, Armstrong RE, Contreras G. Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. Lancet. 1978;2(8102):1248.
12. Hahné S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J. 2009;28(9):795-800.
13. Drebot MA, Mulders MN, Campbell JJ, Kew OM, Fonseca K, Strong D, et al. Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol. 1997;63(2):519-523.
14. van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE. Measles epidemic in the Netherlands, 1999-2000. J Infect Dis. 2002;186(10):1483-1486.
15. Baas MC, van Donselaar KA, Florquin S, van Binnendijk RS, ten Berge IJ, Bemelman FJ. Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant. 2009;9(9):2186-9.
16. Centers for Disease Control and Prevention (CDC). International Classification of Diseases, ninth revision, clinical modification www.eurosurveillance.org 9 (ICD-9-CM). Atlanta: CDC; 2010. [Accessed 19 Jul 2011]. Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm
17. Chan EOM, Carr DJ, Dolman S. Epidemiology of the 2008mumps outbreak in Oxford County, Ontario. [Presentation at the Association of Public Health Epidemiologists in Ontario, (CSEB/APHEO Joint Conference), Ottawa, Ontario, Canada, 24-28 May 2009, and at the Ontario Public Health Conference, Toronto, Ontario, Canada, 1-4 November 2009]. Available from: http://www.ophaconference.ca/2009/pdfs/OPHA09-C06BP1-EChan.pdf
18. Tipples GA, Hiebert J. Detection of measles, mumps, and rubella viruses. In: Stephenson JR, Warnes A, editors. Diagnostic virology protocols: Springer Science and Business Media; 2011. p. 183-93.
19. Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, et al. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol. 2005;150(9):1903-1909.
20. Jin L, Beard S, Brown DW. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis. 1999;180(3):829-833.
21. Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of mumps--United States, January 1-May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006;55(20):559-63.
22. Centers for Disease Control and Prevention (CDC). Mumps outbreak-New York, New Jersey, Quebec, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(45):1270-1274.
23. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis. 2007;45(4):459-466.
24. Public Health Agency of Canada. Update on mumps outbreak in the Maritimes. National summary, September 14, 2007. Available from: http://www.phac-aspc.gc.ca/mumps-oreillons/pdf/mumps-oreillons070914_e.pdf
25. Bijkerk H, Draaisma FJ, van der Gugten AC, van Os M. The poliomyelitis epidemic in 1978. Ned Tijdschr Geneeskd. 1979;123(39):1700-1714. Dutch.
26. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, Rümke HC, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. 1994;344(8923):665-670.
27. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, et al. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine. 2010;28(17):2932-2936.
28. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006. Vaccine. 2008;26(29-30):3601-3607.
29. Park DW, Nam MH, Kim JY, Kim HJ, Sohn JW, Cho Y, et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine. 2007;25(24):4665-4670.
30. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine. 2004;22(21-22):2713-2716.
31. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis. 1994;169(1):77-82.
32. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12-17.
33. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-1589.
34. Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198(4):508-515.
35. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill. 2010;15(17):pii=19554. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19554